MT2-MMP expression associates with tumor progression and angiogenesis in human lung cancer

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 6, 2014, Pages 3469-3477

  Chen, Lujun ^a   Zhou, Qi ^a   Xu, Bin ^a   Liu, Jian ^a   Shi, Liangrong ^a   Zhu, Danxia ^a   Wu, Changping ^a   Jiang, Jingting ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Intratumoral angiogenesis; MT2 MMP; NSCLC; Prognosis

Indexed keywords

MATRIX METALLOPROTEINASE 15; MESSENGER RNA; MMP15 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; BIOSYNTHESIS; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NON SMALL CELL LUNG CANCER; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 15; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84904325205     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Siegel R, Naishadham D, Jemal A. Cancer sta-tistics, 2013. CA Cancer J Clin 2013; 63: 11-30
2. Zhang G, Xu Y, Lu X, Huang H, Zhou Y, Lu B, Zhang X. Diagnosis value of serum B7-H3 ex-pression in non-small cell lung cancer. Lung Cancer 2009; 66: 245-9
3. Konishi J, Yamazaki K, Azuma M, Kinoshita I, Dosaka-Akita H, Nishimura M. B7-H1 expres-sion on non-small cell lung cancer cells and its relationship with tumor-iniltrating lympho-cytes and their PD-1 expression. Clin Cancer Res 2004; 10: 5094-100
4. Littlepage LE, Sternlicht MD, Rougier N, Phil-lips J, Gallo E, Yu Y, Williams K, Brenot A, Gor-don JI, Werb Z. Matrix metalloproteinases con-tribute distinct roles in neuroendocrine pros- tate carcinogenesis, metastasis, and angio-genesis progression. Cancer Res 2010; 70: 2224-34
5. Brinckerhoff CE, Matrisian LM. Matrix metallo-proteinases: a tail of a frog that became a prince. Nature Rev 2002; 3: 207-14
6. Kerkela E, Ala-Aho R, Jeskanen L, Rechardt O, Grenman R, Shapiro SD, Kahari VM, Saarialho-Kere U. Expression of human macrophage me-talloelastase (MMP-12) by tumor cells in skin cancer. J Invest Dermatol 2000; 114: 1113-9
7. Takino T, Watanabe Y, Matsui M, Miyamori H, Kudo T, Seiki M, Sato H. Membrane-type 1 ma-trix metalloproteinase modulates focal adhe-sion stability and cell migration. Exp Cell Res 2006; 312: 1381-9
8. Ueno H, Nakamura H, Inoue M, Imai K, Nogu-chi M, Sato H, Seiki M, Okada Y. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997; 57: 2055-60
9. Gilles C, Polette M, Piette J, Munaut C, Thomp-son EW, Birembaut P, Foidart JM. High level of MT-MMP expression is associated with inva-siveness of cervical cancer cells. Int J Cancer 1996; 65: 209-13
10. Davidson B, Goldberg I, Berner A, Nesland JM, Givant-Horwitz V, Bryne M, Risberg B, Kris-tensen GB, Tropé CG, Kopolovic J, Reich R. Ex-pression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions. Am J Clin Pathol 2001; 115: 517-24
11. Asano T, Tada M, Cheng S, Takemoto N, Kura-mae T, Abe M, Takahashi O, Miyamoto M, Hamada J, Moriuchi T, Kondo S. Prognostic val-ues of matrix metalloproteinase family expres-sion in human colorectal carcinoma. J Surg Res 2008; 146: 32-42
12. Abraham R, Schafer J, Rothe M, Bange J, Knyazev P, Ullrich A.Identiication of MMP-15 as an anti-apoptotic factor in cancer cells. J Biol Chem 2005; 280: 34123-32
13. Chen L, Di D, Luo G, Zheng L, Tan Y, Zhang X, Xu N. Immunochemical staining of MT2-MMP correlates positively to angiogenesis of human esophageal cancer. Anticancer Res 2010; 30: 4363-8
14. Greene FL, Balch CM, Fleming ID, April Fritz R, Haller DG, Morrow M, Page DL. AJCC cancer staging manual. 6th edition. New York: Spring-er-Verlag; 2002
15. Chen LJ, Sun J, Wu HY, Zhou SM, Tan Y, Tan M, Shan BE, Lu BF, Zhang XG. B7-H4 expression associates with cancer progression and pre-dicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother 2011; 60: 1047-55
16. Chen L, Luo G, Tan Y, Wei J, Wu C, Zheng L, Zhang X, Xu N. Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient. Acta Histochem 2010; 112: 233-9
17. Lujun C, Dongmei D, Guanghua L, Lu Z, Yan T, Xiaoying Z, Ning X. Immunochemical staining of MT2-MMP correlates positively to angiogen-esis of human esophageal cancer. Anticancer Res 2010; 30: 4363-8
18. Chen LJ, Sun J, Wu HY, Zhou SM, Tan Y, Tan M, Shan BE, Lu BF, Zhang XG. B7-H4 expression associates with cancer progression and pre-dicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother 2011; 60: 1047-55
19. Bonomi P. Matrix metalloproteinases and ma-trix metalloproteinase inhibitors in lung cancer Sem Oncol 2002; 29 Suppl 4:78-86
20. Roy R, Yang J, Moses MA. Matrix metallopro-teinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin On-col 2009; 27: 5287-97
21. Zheng S, Chang Y, Hodges KB, Sun Y, Ma X, Xue Y, Williamson SR, Lopez-Beltran A, Mon-tironi R, Cheng L. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival. Antican-cer Res 2010; 30: 713-8
22. Kaitu'u-Lino TJ, Palmer K, Tuohey L, Ye L, Tong S. MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce solu-ble endoglin. PLoS One 2012; 7: e39864
23. Sena P, Mariani F, Marzona L, Benincasa M, Ponz de Leon M, Palumbo C, Roncucci L. Ma-trix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages. Int J Oncol 2012; 41: 260-6
24. Tao G, Levay AK, Gridley T, Lincoln J. Mmp15 is a direct target of Snai1 during endothelial to mesenchymal transformation and endocardial cushion development. Dev Biol 2011; 359: 209-21
25. Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 2000; 149: 1309-23
26. Sounni NE, Devy L, Hajitou A, Frankenne F, Mu-naut C, Gilles C, Deroanne C, Thompson EW, Foidart JM, Noel A. MT1-MMP expression pro-motes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 2002; 16: 555-64
27. Sounni NE, Roghi C, Chabottaux V, Janssen M, Munaut C, Maquoi E, Galvez BG, Gilles C, Fran-kenne F, Murphy G, Foidart JM, Noel A. Up-reg-ulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metallopro-teinase through activation of Src-tyrosine ki-nases. J Biol Chem 2004; 279: 13564-74
28. Laleur MA, Handsley MM, Knauper V, Murphy G, Edwards DR. Endothelial tubulogenesis within ibrin gels speciically requires the activ-ity of membrane-type-matrix metalloproteinas-es (MT-MMPs). J Cell Sci 2002; 115: 3427-38
29. Plaisier M, Kapiteijn K, Koolwijk P, Fijten C, Hanemaaijer R, Grimbergen JM, Mulder-Stapel A, Quax PH, Helmerhorst FM, van Hinsbergh VW. Involvement of membrane-type matrix me-talloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascu-lar endothelial cells: role of MT3-MMP. J Clin Endocrinol Metab 2004; 89: 5828-36